NYSE:RRMS (RRMS) (RRMS) Stock Price, News & Analysis → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free RRMS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$27.16▼$27.1650-Day Range N/A52-Week Range$6.67▼$32.44VolumeN/AAverage Volume205,322 shsMarket CapitalizationN/AP/E Ratio63.16Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (RRMS) alerts: Email Address Ad DTIHow a $0.25 cent option contract makes my top traders feelIf you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…Click now to see for yourself what $0.25 Cent Trades is all about About (RRMS) Stock (NYSE:RRMS)Rose Rock Midstream, L.P. owns, operates, develops and acquires diversified portfolio of midstream energy assets. The Company is engaged in providing midstream energy related services, such as crude oil gathering, transportation, storage, distribution and marketing in Colorado, Kansas, Minnesota, Montana, North Dakota, Ohio, Oklahoma, Pennsylvania, Texas and Wyoming. Its segments include Transportation, Facilities, and Supply and Logistics. Its Transportation segment operates crude oil pipelines and truck transportation businesses in the United States. Its Facilities segment operates crude oil storage and terminal businesses in the United States. Its Supply and Logistics segment operates a crude oil marketing and blending business in the United States. The Company operates in the Bakken Shale in North Dakota and Montana, the Denver-Julesburg Basin (DJ Basin) and the Niobrara Shale in the Rocky Mountain region, and the Granite Wash and Mississippi Lime Play in the Mid-Continent region.Read More Ad DTIHow a $0.25 cent option contract makes my top traders feelIf you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…Click now to see for yourself what $0.25 Cent Trades is all about RRMS Stock News HeadlinesApril 10, 2024 | finance.yahoo.comGranite Telecommunications Boosts EPIK Solution with Strategic Rapid Response Monitoring AllianceApril 4, 2024 | markets.businessinsider.comPolTREG identifies promising efficacy biomarker for Type-1 diabetes in patients treated with its Treg therapy in combination with rituximabApril 26, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…March 27, 2024 | msn.comHow Everclear’s Art Alexakis combines rock and comedy to fight MSMarch 26, 2024 | msn.comWhen Does SPMS Begin?March 22, 2024 | msn.comSetPoint joins FDA’s TAP programme with MS deviceMarch 15, 2024 | msn.comUnveiling Atlanta's Culinary Gems with Mike Jordan and Max HinesMarch 14, 2024 | msn.comSetPoint wins second FDA breakthrough device nod for neurostim deviceApril 26, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…March 13, 2024 | sg.finance.yahoo.comExplainer-What is bitcoin's 'halving', and does it matter?March 13, 2024 | finance.yahoo.comSetPoint Medical Receives FDA Breakthrough Device Designation for its Neuroimmune Modulation Platform for the Treatment of Multiple SclerosisMarch 11, 2024 | finanznachrichten.dePolTREG S.A.: PolTREG receives CGMP certification to produce cell therapies at its state-of-the-art manufacturing site in PolandMarch 11, 2024 | markets.businessinsider.comPolTREG receives CGMP certification to produce cell therapies at its state-of-the-art manufacturing site in PolandFebruary 29, 2024 | finance.yahoo.comEMD Serono Presents New MAVENCLAD® Data Supporting Cognitive Function BenefitsFebruary 28, 2024 | msn.comIndia gets breakthrough multiple sclerosis drug, but could be unaffordable to many at Rs 10+ lakh a yrFebruary 27, 2024 | msn.comMultiple sclerosis: SPMS vs. RRMS explainedFebruary 27, 2024 | finance.yahoo.comOM1 to Present Research on Multiple Sclerosis at ACTRIMS Forum 2024February 23, 2024 | msn.comChampioning Justice: Unveiling the Impact of Gideon's Promise at "Igniting Change" EventFebruary 21, 2024 | tmcnet.comPolTREG appoints Dan Shelly as Chief Business Development OfficerFebruary 12, 2024 | msn.comKadarius Toney trade regrade: Who won between Chiefs, Giants after WR's Super Bowl scratchFebruary 1, 2024 | msn.comBlack and Hispanic Women With Multiple Sclerosis Are More Likely to Have Complicated PregnanciesJanuary 31, 2024 | finanznachrichten.deSandoz Group: Sandoz launches first and only biosimilar for multiple sclerosis, Tyruko® (natalizumab), in GermanyJanuary 31, 2024 | msn.comSandoz launches biosimilar for multiple sclerosis in GermanyJanuary 31, 2024 | markets.businessinsider.comSandoz To Launch Tyruko Biosimilar For Multiple Sclerosis In Germany On Feb. 1January 31, 2024 | financialpost.comSandoz launches first and only biosimilar for multiple sclerosis, Tyruko® (natalizumab), in GermanyJanuary 30, 2024 | markets.businessinsider.comPolTREG CEO Trzonkowski co-authors peer-reviewed article showing scientific progress in T-reg autoimmune therapyJanuary 16, 2024 | tmcnet.comPolTREG receives US Patent Office Notice of Allowance for Treg cell therapy to treat Type-1 DiabetesSee More Headlines Receive RRMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (RRMS) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNYSE:RRMS CUSIPN/A CIK1527622 Webwww.semgroupcorp.com Phone+1-918-5248100FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio63.16 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report RRMS Stock Analysis - Frequently Asked Questions Is (RRMS) a good dividend stock? (RRMS) (NYSE:RRMS) pays an annual dividend of $2.64 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 613.95%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for RRMS. What other stocks do shareholders of (RRMS) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (RRMS) investors own include Aegean Marine Petroleum Network (ANW), Chipotle Mexican Grill (CMG), Endologix (ELGX), Express (EXPR), Hudson Technologies (HDSN), Pentair (PNR), Charles Schwab (SCHW), USG (USG), CARBO Ceramics (CRR) and Ritter Pharmaceuticals (RTTR). This page (NYSE:RRMS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (RRMS) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
